Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1Phase 1 1

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 9481Neoplasms 6589Prostatic Neoplasms 4399Colorectal Neoplasms 3978Lung Neoplasms 3644Carcinoma, Non-Small-Cell Lung 3585Pancreatic Neoplasms 2479Carcinoma, Hepatocellular 2413Leukemia, Myeloid, Acute 2265Multiple Myeloma 2121Stomach Neoplasms 2109Neoplasm Metastasis 1911Head and Neck Neoplasms 1870Ovarian Neoplasms 1773Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1730Brain Neoplasms 1702Rectal Neoplasms 1676Melanoma 1656Colonic Neoplasms 1629Leukemia 1500Uterine Cervical Neoplasms 1499Recurrence 1486Esophageal Neoplasms 1312Glioblastoma 1308Lymphoma, Non-Hodgkin 1205Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1078Lymphoma, Follicular 1067

Interventions

Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Colon Cancer Prevention × Clear all
NCT07328308 2026-01-09

Delayed Surveillance Colonoscopy Following Piecemeal EMR

Rambam Health Care Campus

Phase NA Not yet recruiting
760 enrolled
Gastrointestinal

Colon Cancer Prevention

NCT03148119 2018-04-24

Study of QRH-882260 Heptapeptide Application in the Colon

University of Michigan

Phase 1 Terminated
5 enrolled
Gastrointestinal

Colon Cancer Prevention

NCT00668161 2012-11-28

APPEAL

Fred Hutchinson Cancer Center

Phase 2/3 Completed
202 enrolled
Gastrointestinal

Colon Cancer Prevention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡